Firms
Theme

UA

Under Armour, Inc. Class C · NYSE

News

2 latest

No direct coverage yet · Showing articles that mention UA

The Motley Fool

Nike vs. Procter & Gamble: Which Consumer Stock Is a Better Buy in 2026?

The article compares Nike and Procter & Gamble as investment options in 2026. Nike faces a prolonged turnaround with declining sales and a 44.5% stock decline over the past year, while Procter & Gamble demonstrates strong profitability with an 18.4% net margin and consistent dividend growth. The author recommends Procter & Gamble as the more stable choice for long-term investors, citing its recession-resistant business model and 70-year dividend increase streak, while suggesting investors wait for Nike to show sustained earnings improvements before investing.

Zacks Investment Research

Under Armour Sharpens Product Focus as Brand Transformation Advances

Under Armour is executing a brand transformation by reducing its Fall/Winter 2026 assortment by 25% with plans for another 25% SKU reduction over 18 months. While some products like HeatGear and Bouncy Tee show strength, Q1 FY2027 revenues declined 3.2% YoY to $1.1B, with North America down 9%. The company expects mid-single-digit revenue declines for FY2027 but maintains adjusted operating income guidance of $140-160M.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $UA · 0 threads

Sign in to post on $UA

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev